NEW YORK (GenomeWeb News) – Pharmacogenomics firm GenetWorx is locating its headquarters in Glen Allen, Va., in a move that is anticipated to create at least 200 jobs.

The announcement was made earlier this week by Henrico County, where Glen Allen is situated.

Founded in 2012, GenetWorx provides DNA analysis of patients for use by clinicians in support of treatment decisions. The firm offers a test kit, which clinicians can use to collect a patient's DNA with an oral swab. The kit is mailed to GenetWorx for analysis, and the results are mailed back to the clinician.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.